SEARCH

SEARCH BY CITATION

References

  • 1
    Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y. et al., NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002. 100: 31753182.
  • 2
    Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A. and Manz, M. G., Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004. 304: 104107.
  • 3
    Shultz, L. D., Ishikawa, F. and Greiner, D. L., Humanized mice in translational biomedical research. Nat. Rev. Immunol. 2007. 7: 118130.
  • 4
    Baenziger, S., Tussiwand, R., Schlaepfer, E., Mazzucchelli, L., Heikenwalder, M., Kurrer, M. O., Behnke, S. et al., Disseminated and sustained HIV infection in CD34+cord blood cell-transplanted Rag2−/−γc-/- mice. Proc Natl Acad Sci. USA 2006. 103: 1595115956.
  • 5
    Berges, B. K., Wheat, W. H., Palmer, B. E., Connick, E. and Akkina, R., HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/−gamma c−/− (RAG-hu) mouse model. Retrovirology 2006. 3: 76.
  • 6
    Gorantla, S., Sneller, H., Walters, L., Sharp, J. G., Pirruccello, S. J., West, J. T., Wood, C. et al., Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2−/−γc−/− mice. J. Virol. 2007. 81: 27002712.
  • 7
    Zhang, L., Kovalev, G. I. and Su, L., HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007. 109: 29782981.
  • 8
    Watanabe, S., Terashima, K., Ohta, S., Horibata, S., Yajima, M., Shiozawa, Y., Dewan, M. Z. et al., Hematopoietic stem cell-engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007. 109: 212218.
  • 9
    Nakata, H., Maeda, K., Miyakawa, T., Shibayama, S., Matsuo, M., Takaoka, Y., Ito, M. et al., Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model. J. Virol. 2005. 79: 20872096.
  • 10
    Nikolich-Zugich, J., Slifka, M. K. and Messaoudi, I., The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 2004. 4: 123132.
  • 11
    Gorochov, G., Neumann, A. U., Kereveur, A., Parizot, C., Li, T., Katlama, C., Karmochkine, M. et al., Perturbation of CD4+and CD8+T-cell repertoires during progression to AIDS and regulation of the CD4+repertoire during antiviral therapy. Nat. Med. 1998. 4: 215221.
  • 12
    Yahata, T., Ando, K., Nakamura, Y., Ueyama, Y., Shimamura, K., Tamaoki, N., Kato, S. et al., Functional human T lymphocyte development from cord blood CD34+cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J. Immunol. 2002. 169: 204209.
  • 13
    Hiramatsu, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Katamura, K. and Nakahata, T., Complete reconstitution of human lymphocytes from cord blood CD34+cells using the NOD/SCID/γcnull mice model. Blood 2003. 102: 873880.
  • 14
    Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M. and Kourilsky, P., The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 1993. 90: 43194323.
  • 15
    Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M. et al., Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005. 174: 64776489.
  • 16
    Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T. et al., Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 2005. 106: 15651573.
  • 17
    Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K. et al., Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006. 12: 13161322.
  • 18
    Tonomura, N., Habiro, K., Shimizu, A., Sykes, M. and Yang, Y.-G., Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008. 111: 42934296.
  • 19
    Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G. et al., Targeting the nuclear antigen 1 of Epstein–Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 2008. 112: 12311239.
  • 20
    Pasqual, N., Gallagher, M., Aude-Garcia, C., Loiodice, M., Thuderoz, F., Demongeot, J., Ceredig, R. et al., Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire. J. Exp. Med. 2002. 196: 11631173.
  • 21
    Colonna, M., Trinchieri, G. and Liu, Y.-J., Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004. 5: 12191226.
  • 22
    Mackall, C. L., Bare, C. V., Granger, L. A., Sharrow, S. O., Titus, J. A. and Gress, R. E., Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 1996. 156: 46094616.
  • 23
    La Gruta, N. L., Driel, I. R. and Gleeson, P. A., Peripheral T. cell expansion in lymphopenic mice results in a restricted T cell repertoire. Eur. J. Immunol. 2000. 30: 33803386.
  • 24
    Zamisch, M., Moore-Scott, B., Su, D. M., Lucas, P. J., Manley, N. and Richie, E. R., Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J. Immunol. 2005. 174: 6067.
  • 25
    Sportes, C., Hakim, F. T., Memon, S. A., Zhang, H., Chua, K. S., Brown, M. R., Fleisher, T. A. et al., Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 2008. 205: 17011714.
  • 26
    King, C., Ilic, A., Koelsch, K. and Sarvetnick, N., Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004. 117: 265277.
  • 27
    Arruvito, L., Sanz, M., Banham, A. H. and Fainboim, L., Expansion of CD4(+)CD25(+) and FOXP3(+) regulatory T cells during the follicular phase of the menstrual cycle: Implications for human reproduction. J. Immunol. 2007. 178: 25722578.
  • 28
    Mutis, T., van Rijn, R. S., Simonetti, E. R., Aarts-Riemens, T., Emmelot, M. E., van Bloois, L., Martens, A. et al., Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2−/−gammac−/− immunodeficient mice. Clin. Cancer Res. 2006. 12: 55205525.
  • 29
    Legrand, N., Cupedo, T., van Lent, A. U., Ebeli, M. J., Weijer, K., Hanke, T. and Spits, H., Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in human immune system Rag2−/−gammac−/− mice. Blood 2006. 108: 238245.
  • 30
    Jiang, Q., Zhang, L., Wang, R., Jeffrey, J., Washburn, M. L., Brouwer, D., Barbour, S. et al., FoxP3+CD4+regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2−/−γC−/− mice in vivo. Blood 2008. 112: 28582868.
  • 31
    Sun, Z., Denton, P. W., Estes, J. D., Othieno, F. A., Wei, B. L., Wege, A. K., Melkus, M. W. et al., Intrarectal transmission, systemic infection, and CD4+T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 2007. 204: 705714.
  • 32
    Cupedo, T., Crellin, N. K., Papazian, N., Rombouts, E. J., Weijer, K., Grogan, J. L., Fibbe, W. E. et al., Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+CD127+natural killer-like cells. Nat. Immunol. 2009. 10: 6674.
  • 33
    Manz, M. G., Human-hemato-lymphoid-system mice: opportunities and challenge. Immunity 2007. 26: 537541.
  • 34
    Desjardins, D., Huret, C., Dalba, C., Kreppel, F., Kochanek, S., Cosset, F. L., Tangy, F. et al., Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. J. Gene Med. 2009. 11: 313325.
  • 35
    Lauer, G. M., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L., zur Wiesch, J. S. et al., Full-breadth analysis of CD8+T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 2005. 79: 1297912988.
  • 36
    Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M. G. et al., Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 1996. 98: 706714.
  • 37
    Scheeren, F. A., Nagasawa, M., Weijer, K., Cupedo, T., Kirberg, J., Legrand, N. and Spits, H., T cell-independent development and induction of somatic hypermutation in human IgM+IgD+CD27+B cells. J. Exp. Med. 2008. 205: 20332042.